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The nontuberculous mycobacterium (NTM) *Mycobacterium abscessus* is an environmental organism found in soil, water, and other ecological niches, and it acts as an opportunistic pathogen causing diseases ranging from cutaneous to pulmonary infections ([@B1]). Bacterial isolates of *M. abscessus* subsp. *bolletii* (formerly referred to as *M. abscessus* subsp. *massiliense*) ([@B2]) were linked to outbreaks of postsurgical skin infections in multiple Brazilian states from 2003 to 2009 ([@B3]--[@B5]). The epidemic isolates are collectively referred to as BRA100, as they exhibit a unique pulsed-field gel electrophoresis (PFGE) signature and show high levels of resistance to glutaraldehyde, the disinfectant used in most hospital sites that had reported cases ([@B2], [@B4], [@B6]).

The genome of one BRA100 strain, *M. abscessus* subsp. *bolletii* GO-06, from the Brazilian state of Goiás, was previously released ([@B7]), but the sequencing of additional outbreak strains is needed for comparative studies of isolates from different geographic regions. Here, we present the draft genome sequence of a BRA100 strain from Rio de Janeiro, Brazil, called *M. abscessus* subsp. *bolletii* CRM-0020, which was isolated in 2006 from a soft tissue biopsy specimen ([@B4]). The PFGE profile of CRM-0020 showed 13 bands by DraI digestion similar to those of the outbreak strains isolated in the Brazilian states of Goiás and Pará ([@B4]).

The genomic sequence data of CRM-0020 were obtained with Illumina MiSeq (150 bp, paired-end) at 130× coverage and with Roche 454 GS-FLX Titanium (average length, 604 bp) at 10× coverage. MiSeq reads were assembled into contigs with the software packages A5 ([@B8]) and Velvet ([@B9]) that were trimmed into 400-bp pseudo-Sanger reads. A combination of pseudo-Sanger, 454, and MiSeq reads were combined for hybrid assembly using Newbler (Roche). The contigs were ordered by alignment to the *M. abscessus* subsp. *abscessus* reference genome ATCC 19977 ([@B10]) with Mauve 2.3.1 ([@B11]), and genomic features were predicted and annotated using the NCBI Prokaryotic Genome Automatic Annotation Pipeline.

The draft genome of CRM-0020 consists of 44 contigs with an average contig length of 111,245 bp, a total size of 4,840,000 bp, and a G+C content of 64.3%. A total of 4,750 coding sequences (CDSs) were predicted, including 3,378 CDSs (71.1%) with functional annotations and 1,372 CDSs (28.9%) that were annotated as hypothetical proteins. The genome contains 46 tRNAs and one rRNA cistron. A comparative analysis between CRM-0020 and ATCC 19977 revealed that 4,189 CDSs (88.2%) are shared between the two strains, while 561 (11.8%) CDSs are unique to CRM-0020. A single contig (length, 56,466 bp) aligned with 99% identity to the *M. abscessus* subsp. *bolletii* plasmids, pMAB01 ([@B12]) and BRA100 (GenBank accession no. CP003505), and includes 63 predicted CDSs.

Whole-genome sequence alignments revealed 6,217 single nucleotide polymorphisms (SNPs) (1.28 SNPs per Kb) between CRM-0020 and GO-06, showing a low level of divergence among the regional outbreak strains from Brazil. In contrast, 49,354 SNPs (10.2 SNPs per Kb) were observed between CRM-0020 and the type strain of *M. abscessus* subsp. *bolletii* CCUG 48898 ([@B13]), revealing a higher level of divergence between unrelated strains than between outbreak strains.
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This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. [ATFQ00000000](ATFQ00000000). The version described in this paper is version ATFQ01000000.
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